January 9, 2013
Gary M. Winer, President and CEO, AbbVie G.K. AbbVie G.K., a spin-off of Abbott Japan’s proprietary pharmaceutical business that launched operations this month, will deploy a business model centering on R&D specialized in specialty care, President and CEO Gary M...read more